CRANBURY, N.J.--(BUSINESS WIRE)--A recent digital supplement from The American Journal of Managed Care® (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, addresses follicular lymphoma (FL) and the phosphatidylinositol 3-kinase (PI3K) pathway as an emerging treatment option.
In this digital supplement, available online, industry experts discuss the treatment landscape for FL and the PI3K pathway. The supplement also includes Q&As with experts on evolving population health strategies and advances in FL treatment.
“With respect to oncology, we are learning more each day about the human genome, which enables us to better determine which medications patients will and will not respond to. This is changing the way patients are treated and managed,” Sheila M. Arquette, RPh, noted. Regarding the evolving treatment spectrum for FL, Arquette added, “Now it is a much more personalized, precision-(focused) approach to care for all.”
In discussing the PI3K pathway and its role in treating relapsed/refractory cases of FL, Andrew M. Evens, DO, MSc, said, “These agents induce a remission of disease (combined partial and complete remission) between 50% and 60% of the time, which, frankly, is nearly as good as many chemotherapy regimens.”
The articles in this digital supplement explore many aspects of FL treatment, with a specific focus on the benefits of the PI3K pathway. Each article offers expert insight into the evolving treatment landscape.
About The American Journal of Managed Care®
The American Journal of Managed Care® (AJMC®) is a multimedia peer-reviewed, Medline-indexed journal that keeps readers on the forefront of health policy by publishing research relevant to industry decision-makers as they work to promote the efficient delivery of high-quality care. AJMC.com is the essential website for managed care professionals, distributing industry updates daily to leading stakeholders. Other titles in the AJMC® family include The American Journal of Accountable Care® and two evidence-based series, Evidence-Based Oncology™ and Evidence-Based Diabetes Management™. These comprehensive offerings bring together stakeholder views from payers, providers, policymakers and other industry leaders in managed care. To order reprints of articles appearing in AJMC® publications, please contact Gil Hernandez at 609-716-7777, ext. 139.
